Cyclodextrin and antibody-drug conjugate formulations
US9610361B2 · kind B2 · utility
0Cited by
5References
43Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 12, 2014 |
| Grant date | Apr 4, 2017 |
| Priority date | — |
| Expiry date | Mar 12, 2034 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB01D2315/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are formulations, including both liquid and lyophilized formulations, comprising a benzodiazepine anti-body-drug conjugate (ADC) and a cyclodextrin. Also disclosed are methods of purifying mixtures comprising benzodiazepine anti-body-drug conjugates and process drug-related impurities.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.